With the announcement by the FDA last Friday evening (11th December) that they had given emergency approval for the vaccine developed by the Mainz-based BioNTech company and manufactured by its commercial partner Pfizer, we are now able to make initial and preliminary recommendations to Dr Robert Hess Premium clients in the USA.